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The flexibility of human RNAi (RNA interference) machinery to accommodate unconventional structures has 
opened the way for the development of novel RNAi triggering formats, suitable for advanced therapeutic 
applications. Non-classical siRNA structural variants show improved functional features over the conventional 
siRNA formats including increased potency, reduced non-specific responses, and enhanced cellular delivery. 
These non-classical RNAi structures with enhanced structural and functional properties, in combination with 
appropriate delivery vehicles, can be an effective therapeutic module. Here we summarize our recent efforts on 
expanding the structural repertoire of classical siRNAs, using tripodal interfering RNA formats, to develop 
novel RNAi based therapeutics for advanced health-care applications. 
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The salient feature of RNAi technology is their ability to 
utilize the cellular machinery mechanism responsible for the 
post-transcriptional gene silencing (PTGS). RNAi 
mechanism allows targeting of complementary transcripts, 
and this often results in potent down-regulation of gene 
expression in most eukaryotic cells [1]. Short duplex RNA 
units, referred to as small interfering RNAs (siRNAs), are 
regarded as the most powerful PTGS tool available for both 
functional genomics and therapeutic applications. siRNA 
typically featuring 19–21bp long double stranded RNA 
(dsRNA) structure, usually recognized by the RNAi 
machinery, are capable of executing  sequence-dependent 
degradation of target mRNA [2]. Foremost advantage of 
RNAi technology is their ability to knock-out virtually any 
gene in the cells with high degree of specificity, providing a 
broader therapeutic window compared with conventional 
small-molecule drugs. 
Ever since the significance of RNAi technology was 
established on a clinical setting, wide range of gene delivery 
systems have been evaluated for their systemic delivery 
[3].An ideal delivery technology, which can effectively 
regulate the therapeutic response of siRNAs, seems a key 
factor in developing clinically relevant therapeutic RNAi 
platforms. Even with their success in the pre-clinical and 
clinical stages, lipid-based platforms for siRNA delivery 
suffer limitations regarding their safety and target organs 
(mainly targeting liver). Synthetic cationic polymers appear 
to be the most eligible candidate for RNAi delivery, as they 
can be rationally designed to incorporate various functional 
domains capable of executing endosomal buffering and 
tissue targeting [4]. However, the structural incompetency of 
short dsRNAs to form stable and effective nano-complexes 
with cationic polymers remains a major obstacle.  
A conventional siRNA features rigid structure and poor 
charge density, and this often limits its association with the 
polymeric delivery vehicle. Thus, development of 
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unconventional RNAi-triggering structures, with increased 
charge density and improved backbone flexibility, was 
undertaken to enhance the affinity between cationic polymers 
and inhibitory RNAs [5-10]. Chemical conjugation and/or 
complementary hybridization strategies have been employed 
to generate polymeric siRNAs resembling the feature of long 
plasmid DNA, and this allowed the formation of stable 
polyelectrolyte complexes upon interaction with the cationic 
carriers [5-7]. However, unlike conventional siRNAs, these 
polymeric siRNAs lacks well-defined structural format and 
their exact intra-cellular processing mechanism can be 
ambiguous. Therefore, our strategy has been focused mainly 
on developing well-defined RNAi triggering units, by taking 
advantage of facile complementary hybridization strategy 
[11-13].  
In an effort to develop novel RNA interfering molecules 
with superior gene silencing and enhanced delivery efficacy 
over conventional siRNAs, we designed a 
tripodal-interfering RNA (tiRNA) format with multiple gene 
targeting capability [12]. This structure was designed via 
complementary base paring strategy, by paring three single 
stranded RNA (ssRNA) units. Combination of three ssRNAs 
resulted in the formation of Y-shaped dsRNA structures, 
with three different siRNA sequences embedded at each arm 
(Figure 1). For each arm, antisense sequence against target 
mRNA was paired with a complementary sense sequence 
from another ssRNA, similar to that of classical siRNAs. In 
other words, a tiRNA structure can be considered as a 
combination of three different siRNAs held in a tripodal 
structural format. Apart from their ability to knock-down 
multiple genes simultaneously, salient feature of tiRNA 
structures was their superior gene silencing efficacy 
compared with conventional siRNA structures, especially 
when combined with conventional cationic polymers.  
Figure 1. Schematic representation of tripodal interfering RNA (tiRNA) structure. Tripodal 
interfering RNA (tiRNA) was constructed via complementary base paring of three single stranded 
RNA (ssRNA) units. Each 5’ terminus of the tiRNA structure encodes target sequence of interest and 
this structure can implement multi-target gene silencing. (Complementary sequences share same 
color coding in this scheme). 
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Our original tiRNA structure was constructed by 
annealing three 38-nt ssRNAs, with each duplex region in the 
tiRNA composed of a 19 bp siRNA unit. We first constructed 
a tiRNA structure harboring three siRNA units intended for 
silencing Lamin A/C (siLamin), DBP (siDBP), and TIG3 
(siTIG3) mRNA, respectively. This tiRNA structure was 
capable of executing multiple-target gene silencing with 
enhanced RNAi efficacy, over corresponding mixture of 
conventional siRNAs, when complexed with positively 
charged cationic polymers [12]. Physicochemical studies 
supported the concept that the efficacy of tiRNA structure was 
largely due to their enhanced interaction with cationic 
polymers, possibly due to the increased charge density and 
molecular flexibility of the RNA units. Compared with other 
non-conventional RNAi triggering formats, such as polymeric 
siRNAs, the tripodal structure retains a well-defined structure 
and can execute specific RNAi-mediated gene silencing 
without the induction of any innate immune response.  
We have also designed a well-defined T-tiRNA structure 
(T-tiSurvivin) that harbors three RNAi units of siSurvivin, 
with a trebler-DNA core [13]. In this structure, nucleotide 
extension was provided at the 3’-end of the antisense strand to 
facilitate interaction with the trebler-DNA core. T-tiRNA 
stucture was so designed that the 5’ region of the antisense 
strand of each siRNA units was orientated towards the outside 
region, and this format retains the gene silencing activity of 
the individual siRNAs. When complexed with cationic 
delivery vehicles, quite similar to that with tiRNAs, T-tiRNAs 
showed enhanced gene knock-down efficacy over 
conventional siRNA mixture.  
Next, we set out to investigate the optimal size limit of 
tripodal RNA structure for effective gene silencing activity. 
To address this issue, we constructed surrogate nucleic acid 
tripodal structures using complementary DNA units and their 
interaction with cationic polymers were studied 
systematically [14]. tiDNA of varying length were designed by 
changing the length of backbones DNA units and their 
complexation efficacy with  cationic polymer was evaluated. 
By using ssDNA of size ranging from 16-40 nt, we observed 
that DNA units shorter than 26nt were unable to form the 
expected tripodal structure. In due course of experiments, we 
also observed that tiRNA composed of 32nt units was most 
appropriate of our experiments, and further experiments were 
performed with this structural format.  
In an effort to choose the most appropriate delivery system 
for tiRNA delivery in vivo, we screened several potential 
candidates. Cationic polymers composed of 
polyethyleneimine units were polymers of our choice, owing 
to their inherent nucleic acid binding capability and the ability 
to facilitate endosomal escape pathways for the RNAi 
triggers[15]. However, the nucleic acid delivering ability of PEI 
is largely jeopardized by their toxicity effects; efforts have 
been made to develop biocompatible delivery system based 
on PEI units while retaining their nucleic acid delivering 
ability. In our studies, we choose a linear version of PEI, 
with 25 kDa, which is largely used in the delivery of pDNA. 
Linear PEI is not considered an effective reagent for siRNAs, 
largely due to their inability to deliver short RNA versions. 
With the introduction of tiRNA structure, we expected 
improved RNA-polymer association and this might further 
enhance their therapeutic potential. Physico-chemical 
characterizations clearly validated our expectations, as 
tiRNA structure formed stable nano-sized complex with 
linear PEI and showed much higher cellular uptake in our 
preliminary in vitro studies [14].  
We then tested whether improved physico-chemical 
properties of tiRNA-PEI complex would be translated into an 
actual RNAi efficacy. This was validated with gene 
knock-down experiments using qRT-PCR, by checking the 
relative expression of endogenous targets in cancer cells with 
respect to house-keeping gene (GAPDH). The results clearly 
demonstrated the efficacy of tiRNA molecules over siRNA 
counterparts with PEI-based delivery system [14]. Next, efforts 
were made to include a targeting moiety to our tiRNA-PEI 
complex. We designed a liver-targeting delivery system based 
on galactose-modified PEI and this was further complexed 
with tiRNA structure. With a conclusive proof-of-concept in 
our in vitro experiments, we decided to perform an in vivo 
efficacy test for tiRNA.  
We chose to use an Apolipoprotein B (ApoB)-targeting 
tiRNA sequences for in vivo investigations. Three different 
ApoB-targeting sequences were assembled into a single 
tiRNA format, and activity test was performed on in vivo 
animal models along with their siRNA counterparts. Results 
clearly validated the efficacy of tiRNA formats even under in 
vivo conditions. tiRNA assembled with cationic polymers 
were more effective in reducing ApoB mRNA level 
compared to a combination of siRNAs with similar carrier. 
Considering the therapeutic potential, these functional 
RNA structures may offer researchers a novel tool for 
targeting multiple disease genes with enhanced therapeutic 
efficacy. However, the exact response of RNAi machinery 
towards these unconventional RNAi triggers is still unclear; 
further studies are required to elucidate the exact intracellular 
processing mechanism. Nevertheless, our studies indicate that 
the design of novel siRNA structural variants may provide 
alternative options to combat various diseases with improved 
safety and efficacy.  
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